IRIS
SAMMARTINO, JOSE' CAMILLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.427
AS - Asia 991
EU - Europa 867
SA - Sud America 157
AF - Africa 28
Totale 3.470
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.370
CN - Cina 333
SG - Singapore 271
HK - Hong Kong 204
RU - Federazione Russa 188
IE - Irlanda 148
DE - Germania 143
BR - Brasile 131
IT - Italia 116
FI - Finlandia 92
VN - Vietnam 57
GB - Regno Unito 50
CA - Canada 39
IN - India 30
JP - Giappone 28
ES - Italia 21
FR - Francia 21
SE - Svezia 19
BD - Bangladesh 17
PL - Polonia 17
ZA - Sudafrica 14
AT - Austria 13
MX - Messico 12
TR - Turchia 11
NL - Olanda 9
VE - Venezuela 9
ID - Indonesia 8
CZ - Repubblica Ceca 5
EC - Ecuador 5
LT - Lituania 5
CH - Svizzera 4
IQ - Iraq 4
PK - Pakistan 4
SA - Arabia Saudita 4
UA - Ucraina 4
AR - Argentina 3
BE - Belgio 3
JM - Giamaica 3
CL - Cile 2
EG - Egitto 2
HU - Ungheria 2
IL - Israele 2
KE - Kenya 2
KG - Kirghizistan 2
KR - Corea 2
MA - Marocco 2
PE - Perù 2
PT - Portogallo 2
PY - Paraguay 2
RO - Romania 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CO - Colombia 1
DM - Dominica 1
DZ - Algeria 1
ET - Etiopia 1
GA - Gabon 1
HR - Croazia 1
IR - Iran 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
MN - Mongolia 1
MY - Malesia 1
MZ - Mozambico 1
NA - Namibia 1
NI - Nicaragua 1
PH - Filippine 1
QA - Qatar 1
SN - Senegal 1
SR - Suriname 1
SV - El Salvador 1
TH - Thailandia 1
TM - Turkmenistan 1
TN - Tunisia 1
TW - Taiwan 1
UY - Uruguay 1
Totale 3.470
Salva come PNG Salva come JPEG
Città #
Hong Kong 204
Dallas 185
Ashburn 162
Dublin 140
Singapore 137
Beijing 121
Chandler 121
New York 91
Munich 81
Boardman 68
Helsinki 64
Los Angeles 55
Shanghai 50
Moscow 32
Ho Chi Minh City 29
Redondo Beach 29
Turku 28
The Dalles 27
Pavia 24
Princeton 20
Lawrence 19
Milan 19
Santa Clara 19
Medford 18
Tokyo 18
Buffalo 16
Warsaw 16
Denver 15
Seattle 15
Toronto 15
Stockholm 14
Montreal 13
Wilmington 13
Chicago 12
Columbus 12
Orem 12
Brooklyn 11
Chennai 11
Frankfurt am Main 11
Poplar 11
São Paulo 11
Boston 10
Johannesburg 10
Nuremberg 10
Charlotte 9
Düsseldorf 9
Hanoi 9
London 9
Rome 9
Washington 9
Ann Arbor 8
Lecce 8
Amsterdam 7
Houston 7
Nanjing 7
Shenyang 7
Changsha 6
Falkenstein 6
Hangzhou 6
Jakarta 6
Utrera 6
Ankara 5
Atlanta 5
Belo Horizonte 5
Mexico City 5
Phoenix 5
San Francisco 5
Brasília 4
Dearborn 4
Honolulu 4
Lauterbourg 4
Manchester 4
Mumbai 4
Nanchang 4
New Delhi 4
Olomouc 4
Bologna 3
Boves 3
Brussels 3
Cuenca 3
Elk Grove Village 3
Ferrara 3
Gallarate 3
Guangzhou 3
Haiphong 3
Kunming 3
Lodi 3
Naples 3
Ottawa 3
Paris 3
Piscataway 3
Porto Alegre 3
Tianjin 3
Vienna 3
Asunción 2
Barcelona 2
Betim 2
Bexley 2
Bishkek 2
Biên Hòa 2
Totale 2.259
Salva come PNG Salva come JPEG
Nome #
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study 124
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up 102
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study 93
SARS-CoV-2 vaccine breakthrough infections with the alpha variant are asymptomatic or mildly symptomatic among health care workers 91
Rv0579 Is Involved in the Resistance to the TP053 Antitubercular Prodrug 90
Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice 90
New insights into the mechanism of action of the thienopyrimidine antitubercular prodrug TP053 89
Design and Synthesis of Pyrano[3,2-b]indolones Showing Antimycobacterial Activity 87
19n01, a Broadly Neutralizing Antibody Against Omicron BA.1, BA.2, BA.4/5, and Other SARS-CoV-2 Variants of Concern 86
An Overview on the Potential Antimycobacterial Agents Targeting Serine/Threonine Protein Kinases from Mycobacterium tuberculosis 86
Targeting iron uptake pathway for the development of novel antitubercular drugs. 85
Characterization of immune response against monkeypox virus in cohorts of infected patients, historic and newly vaccinated subjects 83
Multitargeting Compounds: A Promising Strategy to Overcome Multi-Drug Resistant Tuberculosis 75
Design, synthesis and evaluation of covalent inhibitors of DprE1 as antitubercular agents 75
Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: a longitudinal observational study 74
Functional investigation of the antitubercular drug target Decaprenylphosphoryl-β-D-ribofuranose-2-epimerase DprE1/DprE2 complex 74
Differential Kinetics of Effector and Memory Responses Induced by Three Doses of SARS-CoV-2 mRNA Vaccine in a Cohort of Healthcare Workers 73
Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort study 72
Immunity to SARS-CoV-2 up to 15 months after infection 64
Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in ∼40% of patients 64
First triclosan-based macrocyclic inhibitors of InhA enzyme 64
Macrophages and monocytes: “trojan horses” in covid-19 63
Variant of Concern-Matched COVID-19 Convalescent Plasma Usage in Seronegative Hospitalized Patients 63
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up 62
Comparative analysis of the chemical composition and microstructure conformation between different dental implant Bone Drills 60
In vitro Study of Bedaquiline Resistance in Mycobacterium tuberculosis Multi-Drug Resistant Clinical Isolates. 60
Humoral and cellular response before and after the fourth BNT162b2 vaccine dose in patients with solid tumors on active treatment 59
Adapting Neutralizing Antibodies to Viral Variants by Structure-Guided Affinity Maturation Using Phage Display Technology 58
Effect of a Third Dose of SARS-CoV-2 mRNA BNT162b2 Vaccine on Humoral and Cellular Responses and Serum Anti-HLA Antibodies in Kidney Transplant Recipients 58
Effect of different surface treatments on titanium dental implant micro-morphology 58
Immunosuppressive treatments selectively affect the humoral and cellular response to SARS-CoV-2 in vaccinated patients with vasculitis 57
New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents 57
Mycobacterium abscessus, an Emerging and Worrisome Pathogen among Cystic Fibrosis Patients. 56
Shedding X-ray light on the role of magnesium in the activity of M. tuberculosis salicylate synthase (MbtI) for drug design 56
The Veterinary Anti-Parasitic Selamectin Is a Novel Inhibitor of the Mycobacterium tuberculosis DprE1 Enzyme 55
Neutralizing antibody levels against SARS-CoV-2 variants of concern Delta and Omicron in vaccine breakthrough-infected blood donors 54
Effect of different titanium dental implant surfaces on human adipose mesenchymal stem cell behavior. An in vitro comparative study 54
Annotation process, guidelines and text corpus of small non-coding RNA molecules: The MiNCor for microRNA annotations 53
mRNA BNT162b Vaccine Elicited Higher Antibody and CD4+ T-Cell Responses than Patients with Mild COVID-19 52
Evaluation of the Neutralizing Antibodies Response against 14 SARS-CoV-2 Variants in BNT162b2 Vaccinated Naïve and COVID-19 Positive Healthcare Workers from a Northern Italian Hospital 51
Dynamics of viral DNA shedding and culture viral DNA positivity in different clinical samples collected during the 2022 mpox outbreak in Lombardy, Italy 50
Characterization of CCP: Can We Use Past Convalescent Plasma from COVID-19 Patients for Treatment of New Emerging Variants? 48
P146 New weapons are necessary to fight Mycobacterium abscessus 48
Local delivery of the hemostatic agent tranexamic acid in chronically anticoagulated patients 48
Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant 46
Six-month humoral and cellular immune response to the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors: a longitudinal cohort study with a focus on the variants of concern 46
Real-life lack of evidence of viable SARS-CoV-2 transmission via inanimate surfaces: The SURFACE study 46
Clinical Influence of Micromorphological Structure of Dental Implant Bone Drills 44
Effect of Low Copper Doping on the Optical, Cytocompatible, Antibacterial, and SARS-CoV-2 Trapping Properties of Calcium Phosphate Glasses 42
SARS-CoV-2 variants inactivation of plasma units using a riboflavin and ultraviolet light-based photochemical treatment 41
Robust and persistent b-and t-cell responses after covid-19 in immunocompetent and solid organ transplant recipient patients 41
High-throughput peptide array analysis and computational techniques for serological profiling of flavivirus infections: Implications for diagnostics and vaccine development 41
White cell and platelet content affects the release of bioactive factors in different blood-derived scaffolds 40
Immune response to bnt162b2 in solid organ transplant recipients: Negative impact of mycophenolate and high responsiveness of sars-cov-2 recovered subjects against delta variant 40
Genotyping of Toxoplasma gondii strain directly from human CSF samples of congenital toxoplasmosis clinical case 36
Platelet-rich plasma counteracts detrimental effect of high-glucose concentrations on mesenchymal stem cells from Bichat fat pad 36
Micro-scale surface patterning of titanium dental implants by anodization in the presence of modifying salts 33
Fitness cost of rifampin resistance in Neisseria meningitidis: In Vitro study of mechanisms associated with rpoB H553Y mutation 23
Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant 21
Totale 3.597
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.439
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.439
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202123 0 0 0 0 0 2 4 15 1 0 0 1
2021/2022100 0 1 0 9 1 1 3 6 6 12 11 50
2022/2023448 32 40 3 29 27 24 0 16 240 13 21 3
2023/2024477 44 90 32 23 38 126 35 24 2 16 12 35
2024/20251.103 28 68 15 22 24 76 67 51 273 72 162 245
2025/20261.349 192 157 283 328 303 86 0 0 0 0 0 0
Totale 3.597